Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL)
Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications through its operating companies. Endo International is headquartered in Dublin, Ireland. U.S. headquarters are in Malvern, PA.